ID   MM96E
AC   CVCL_D852
SY   96E; MM96 Early passage
DR   cancercelllines; CVCL_D852
DR   Wikidata; Q54906196
RX   PubMed=1422191;
RX   PubMed=2798324;
RX   PubMed=3127479;
CC   Characteristics: Lightly pigmented.
CC   Doubling time: 23.5 hours (PubMed=2798324).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D848 ! MM96
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
RX   PubMed=1422191; DOI=10.1097/00008390-199201000-00007;
RA   Takahashi H., Schumann R., Quinn R.J., Briscoe T.A., Parsons P.G.;
RT   "Isomers of a marine diterpene distinguish sublines of human melanoma
RT   cells on the basis of apoptosis, cell cycle arrest and differentiation
RT   markers.";
RL   Melanoma Res. 1:359-366(1992).
//
RX   PubMed=2798324; DOI=10.1111/j.1600-0749.1989.tb00211.x;
RA   Brown J.K., Mountford M.H., Allen B.J., Mishima Y., Ichihashi M.,
RA   Parsons P.G.;
RT   "Neutron irradiation of human melanoma cells.";
RL   Pigment Cell Res. 2:319-324(1989).
//
RX   PubMed=3127479; DOI=10.1111/1523-1747.ep12461022;
RA   McEwan M., Parsons P.G., Moss D.J.;
RT   "Monoclonal antibody against human tyrosinase and reactive with
RT   melanotic and amelanotic melanoma cells.";
RL   J. Invest. Dermatol. 90:515-519(1988).
//